Dr. Thompson was co-director of the center’s melanoma clinic and has led the Fred Hutch Phase 1 Clinical Trials program since 2008, according to a Dec. 19 news release from the center.
He was also a professor in the center’s clinical research division and in the division of hematology and oncology at Seattle-based University of Washington School of Medicine.
After joining Fred Hutch in 1985, Dr. Thompson was among a group of investigators who focused on testing new immunotherapy treatments, laying the groundwork for treatments seen today, the release said.